Search

5 result(s) for 'author#"Chikao Sugie"' within BMC

1. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size

   The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that stage IB patients had worse outcomes than stage IA pa...

   Authors: Fumiya Baba, Yuta Shibamoto, Hiroyuki Ogino, Rumi Murata, Chikao Sugie, Hiromitsu Iwata, Shinya Otsuka, Katsura Kosaki, Aiko Nagai, Taro Murai and Akifumi Miyakawa

   Citation: Radiation Oncology 2010 5:81

   Content type: Research

   Published on: 17 September 2010

   • View Full Text
   • View PDF

2. Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode

   With the new mode of Tomotherapy, irradiation can be delivered using static ports of the TomoDirect mode. The purpose of this study was to evaluate the characteristics of TomoDirect plans compared to conventio...

   Authors: Taro Murai, Yuta Shibamoto, Yoshihiko Manabe, Rumi Murata, Chikao Sugie, Akihiro Hayashi, Hiroya Ito and Yoshihito Miyoshi

   Citation: Radiation Oncology 2013 8:68

   Content type: Research

   Published on: 21 March 2013

   • View Full Text
   • View PDF

3. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results

   In stereotactic body radiotherapy (SBRT) for lung tumors, reducing tumor movement is necessary. In this study, we evaluated changes in tumor movement and percutaneous oxygen saturation (SpO₂) levels, and prelimin...

   Authors: Fumiya Baba, Yuta Shibamoto, Natsuo Tomita, Chisa Ikeya-Hashizume, Kyota Oda, Shiho Ayakawa, Hiroyuki Ogino and Chikao Sugie

   Citation: Radiation Oncology 2009 4:15

   Content type: Research

   Published on: 28 May 2009

   • View Full Text
   • View PDF

4. Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer

   Radiation proctitis after intensity-modulated radiation therapy (IMRT) differs from that seen after pelvic irradiation in that this adverse event is a result of high-dose radiation to a very small area in the ...

   Authors: Shinya Takemoto, Yuta Shibamoto, Shiho Ayakawa, Aiko Nagai, Akihiro Hayashi, Hiroyuki Ogino, Fumiya Baba, Takeshi Yanagi, Chikao Sugie, Hiromi Kataoka and Mikio Mimura

   Citation: Radiation Oncology 2012 7:87

   Content type: Research

   Published on: 12 June 2012

   • View Full Text
   • View PDF

5. Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study

   Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often emplo...

   Authors: Akifumi Miyakawa, Yuta Shibamoto, Fumiya Baba, Yoshihiko Manabe, Taro Murai, Chikao Sugie, Takeshi Yanagi and Taiki Takaoka

   Citation: Radiation Oncology 2017 12:152

   Content type: Research

   Published on: 11 September 2017

   • View Full Text
   • View PDF